10-80274506-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000429.3(MAT1A):​c.1085+14C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.475 in 1,613,602 control chromosomes in the GnomAD database, including 187,721 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.54 ( 23804 hom., cov: 32)
Exomes 𝑓: 0.47 ( 163917 hom. )

Consequence

MAT1A
NM_000429.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.117

Publications

15 publications found
Variant links:
Genes affected
MAT1A (HGNC:6903): (methionine adenosyltransferase 1A) This gene catalyzes a two-step reaction that involves the transfer of the adenosyl moiety of ATP to methionine to form S-adenosylmethionine and tripolyphosphate, which is subsequently cleaved to PPi and Pi. S-adenosylmethionine is the source of methyl groups for most biological methylations. The encoded protein is found as a homotetramer (MAT I) or a homodimer (MAT III) whereas a third form, MAT II (gamma), is encoded by the MAT2A gene. Mutations in this gene are associated with methionine adenosyltransferase deficiency. [provided by RefSeq, Jul 2008]
MAT1A Gene-Disease associations (from GenCC):
  • methionine adenosyltransferase deficiency
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 10-80274506-G-A is Benign according to our data. Variant chr10-80274506-G-A is described in ClinVar as [Benign]. Clinvar id is 256103.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.74 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MAT1ANM_000429.3 linkc.1085+14C>T intron_variant Intron 8 of 8 ENST00000372213.8 NP_000420.1 Q00266

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MAT1AENST00000372213.8 linkc.1085+14C>T intron_variant Intron 8 of 8 1 NM_000429.3 ENSP00000361287.3 Q00266
MAT1AENST00000480845.1 linkn.317+14C>T intron_variant Intron 2 of 4 3
MAT1AENST00000485270.5 linkn.597+14C>T intron_variant Intron 2 of 2 2

Frequencies

GnomAD3 genomes
AF:
0.543
AC:
82509
AN:
151952
Hom.:
23765
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.747
Gnomad AMI
AF:
0.345
Gnomad AMR
AF:
0.542
Gnomad ASJ
AF:
0.470
Gnomad EAS
AF:
0.452
Gnomad SAS
AF:
0.645
Gnomad FIN
AF:
0.424
Gnomad MID
AF:
0.484
Gnomad NFE
AF:
0.444
Gnomad OTH
AF:
0.516
GnomAD2 exomes
AF:
0.506
AC:
127090
AN:
251288
AF XY:
0.505
show subpopulations
Gnomad AFR exome
AF:
0.753
Gnomad AMR exome
AF:
0.544
Gnomad ASJ exome
AF:
0.479
Gnomad EAS exome
AF:
0.455
Gnomad FIN exome
AF:
0.430
Gnomad NFE exome
AF:
0.453
Gnomad OTH exome
AF:
0.496
GnomAD4 exome
AF:
0.468
AC:
683826
AN:
1461532
Hom.:
163917
Cov.:
49
AF XY:
0.471
AC XY:
342566
AN XY:
727082
show subpopulations
African (AFR)
AF:
0.759
AC:
25422
AN:
33474
American (AMR)
AF:
0.548
AC:
24487
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.476
AC:
12445
AN:
26122
East Asian (EAS)
AF:
0.408
AC:
16183
AN:
39690
South Asian (SAS)
AF:
0.625
AC:
53947
AN:
86250
European-Finnish (FIN)
AF:
0.429
AC:
22888
AN:
53372
Middle Eastern (MID)
AF:
0.555
AC:
3199
AN:
5768
European-Non Finnish (NFE)
AF:
0.446
AC:
495706
AN:
1111750
Other (OTH)
AF:
0.489
AC:
29549
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
22009
44017
66026
88034
110043
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15240
30480
45720
60960
76200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.543
AC:
82611
AN:
152070
Hom.:
23804
Cov.:
32
AF XY:
0.546
AC XY:
40551
AN XY:
74336
show subpopulations
African (AFR)
AF:
0.747
AC:
30991
AN:
41488
American (AMR)
AF:
0.543
AC:
8297
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.470
AC:
1632
AN:
3470
East Asian (EAS)
AF:
0.453
AC:
2334
AN:
5152
South Asian (SAS)
AF:
0.646
AC:
3115
AN:
4820
European-Finnish (FIN)
AF:
0.424
AC:
4484
AN:
10574
Middle Eastern (MID)
AF:
0.497
AC:
146
AN:
294
European-Non Finnish (NFE)
AF:
0.444
AC:
30205
AN:
67970
Other (OTH)
AF:
0.519
AC:
1094
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1815
3629
5444
7258
9073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
706
1412
2118
2824
3530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.485
Hom.:
53507
Bravo
AF:
0.556
Asia WGS
AF:
0.573
AC:
1995
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hepatic methionine adenosyltransferase deficiency Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.13
DANN
Benign
0.52
PhyloP100
-0.12
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2994388; hg19: chr10-82034262; COSMIC: COSV64745501; COSMIC: COSV64745501; API